Technical Analysis for PRPH - ProPhase Labs, Inc.

Grade Last Price % Change Price Change
grade F 2.3 -9.09% -0.23
PRPH closed down 9.09 percent on Wednesday, June 26, 2019, on 3.85 times normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Down Down Down
See historical PRPH trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Expansion Breakdown Bearish Swing Setup 0.00%
Volume Surge Other 0.00%
Wide Range Bar Range Expansion 0.00%
Lower Bollinger Band Walk Weakness 0.00%
New 52 Week Low Weakness 0.00%
Below Lower BB Weakness 0.00%
Down 3 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%

Older signals for PRPH ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
ProPhase Labs, Inc. engages in the manufacture, marketing, and distribution of homeopathic and health products to the general public. It is also involved in the research and development of over-the-counter (OTC) drugs, natural base health products with supplements, personal care, and cosmeceutical products. The company offers Cold-EEZE, a zinc gluconate glycine lozenge to reduce the duration and severity of the common cold symptoms. It also markets and distributes two non-lozenge forms of its proprietary zinc gluconate formulation, Cold-EEZE daytime/nighttime QuickMelts and Cold-EEZE oral spray; and Kids-EEZE products for children suffering from upper respiratory infections, allergy, and/or chest congestion, as well as organic cough drops and a Vitamin C supplements. It also provides private label lozenge products for retail customers; and performs contract manufacturing services of cough drop and other OTC cold remedy products for third parties. ProPhase Labs, Inc. sells its products through food, multi-outlet pharmacy and chain drug stores, wholesalers, and mass merchandisers in the United States. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Doylestown, Pennsylvania.
Chemistry Health Food Physical Sciences Retail Customers Dietary Supplements Allergy Zinc Contract Manufacturing Services Over The Counter Drug Health Products Cough
Is PRPH a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 4.0
52 Week Low 2.145
Average Volume 9,912
200-Day Moving Average 3.0248
50-Day Moving Average 2.9587
20-Day Moving Average 2.894
10-Day Moving Average 2.841
Average True Range 0.1346
ADX 50.43
+DI 3.2951
-DI 53.7939
Chandelier Exit (Long, 3 ATRs ) 2.6687
Chandelier Exit (Short, 3 ATRs ) 2.5488
Upper Bollinger Band 3.2525
Lower Bollinger Band 2.5355
Percent B (%b) -0.33
BandWidth 24.775397
MACD Line -0.0984
MACD Signal Line -0.0383
MACD Histogram -0.0601
Fundamentals Value
Market Cap 37.18 Million
Num Shares 16.2 Million
EPS 2.40
Price-to-Earnings (P/E) Ratio 0.96
Price-to-Sales 1.57
Price-to-Book 0.73
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.89
Resistance 3 (R3) 2.91 2.72 2.79
Resistance 2 (R2) 2.72 2.57 2.72 2.76
Resistance 1 (R1) 2.51 2.48 2.42 2.50 2.73
Pivot Point 2.33 2.33 2.28 2.32 2.33
Support 1 (S1) 2.12 2.18 2.02 2.10 1.87
Support 2 (S2) 1.93 2.08 1.93 1.84
Support 3 (S3) 1.72 1.93 1.81
Support 4 (S4) 1.71